BDBM37572 2-[(1,3-dimethyl-2,4-dioxo-6-quinazolinyl)sulfonylamino]-N-(3-methoxypropyl)-3-phenylpropanamide::2-[(1,3-dimethyl-2,4-dioxoquinazolin-6-yl)sulfonylamino]-N-(3-methoxypropyl)-3-phenylpropanamide::2-[(2,4-diketo-1,3-dimethyl-quinazolin-6-yl)sulfonylamino]-N-(3-methoxypropyl)-3-phenyl-propionamide::2-[[1,3-dimethyl-2,4-bis(oxidanylidene)quinazolin-6-yl]sulfonylamino]-N-(3-methoxypropyl)-3-phenyl-propanamide::MLS000092533::N-[(1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-6-yl)sulfonyl]-N-(3-methoxypropyl)phenylalaninamide::SMR000028081::cid_3244505
SMILES COCCCNC(=O)C(Cc1ccccc1)NS(=O)(=O)c1ccc2n(C)c(=O)n(C)c(=O)c2c1
InChI Key InChIKey=MBUGLSMMSAFPQF-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37572
TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair